| Breakdown | TTM | Mar 2025 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 1.15B | 1.15B | 1.14B | 900.50M | 947.00M | 847.10M |
| Gross Profit | 424.40M | 439.30M | 432.30M | 327.10M | 335.30M | 297.50M |
| EBITDA | 241.80M | 232.10M | 225.30M | 169.70M | 208.30M | 145.70M |
| Net Income | 132.20M | 124.90M | 112.50M | 77.50M | 106.00M | 46.50M |
Balance Sheet | ||||||
| Total Assets | 2.21B | 2.25B | 2.33B | 2.53B | 2.27B | 3.03B |
| Cash, Cash Equivalents and Short-Term Investments | 127.40M | 191.50M | 102.30M | 54.30M | 4.20M | 177.90M |
| Total Debt | 334.50M | 335.10M | 337.90M | 339.30M | 336.90M | 607.50M |
| Total Liabilities | 814.70M | 809.70M | 1.01B | 1.03B | 1.09B | 1.35B |
| Stockholders Equity | 1.39B | 1.44B | 1.33B | 1.51B | 1.18B | 1.68B |
Cash Flow | ||||||
| Free Cash Flow | 106.90M | 116.70M | 88.90M | 66.90M | 62.00M | 73.10M |
| Operating Cash Flow | 140.30M | 158.10M | 121.70M | 90.10M | 85.60M | 85.90M |
| Investing Cash Flow | -95.75M | -41.40M | -62.10M | -23.20M | 13.80M | -18.00M |
| Financing Cash Flow | -46.00M | -27.50M | -20.70M | -13.70M | -276.20M | 82.20M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | £2.74B | 8.36 | 15.07% | 2.06% | 6.96% | 28.47% | |
76 Outperform | £1.56B | 8.95 | 10.71% | 1.62% | 0.50% | 20.52% | |
71 Outperform | £432.88M | 11.83 | 12.72% | 7.01% | 8.58% | -15.81% | |
70 Outperform | £1.91B | 17.26 | 12.23% | 0.79% | 7.74% | 30.09% | |
65 Neutral | £1.54B | 8.87 | 2.17% | 5.27% | 26.84% | -81.73% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% |